Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9.
The discovery of RNAi has revolutionized loss-of-function genetic studies in mammalian systems. However, significant challenges still remain to fully exploit RNAi for mammalian genetics. For instance, genetic screens and in vivo studies could be broadly improved by methods that allow inducible and uniform gene expression control. To achieve this, we built the lentiviral pINDUCER series of expression vehicles for inducible RNAi in vivo. Using a multicistronic design, pINDUCER vehicles enable tracking of viral transduction and shRNA or cDNA induction in a broad spectrum of mammalian cell types in vivo. They achieve this uniform temporal, dose-dependent, and reversible control of gene expression across heterogenous cell populations via fluorescence-based quantification of reverse tet-transactivator expression. This feature allows isolation of cell populations that exhibit a potent, inducible target knockdown in vitro and in vivo that can be used in human xenotransplantation models to examine cancer drug targets.
RNAi 的发现彻底改变了哺乳动物系统中丧失功能的遗传研究。然而,要充分利用 RNAi 进行哺乳动物遗传学研究,仍然存在重大挑战。例如,通过允许诱导和均匀基因表达控制的方法,遗传筛选和体内研究可以得到广泛改善。为了实现这一目标,我们构建了用于体内诱导 RNAi 的慢病毒 pINDUCER 表达载体系列。使用多顺反子设计,pINDUCER 载体可在体内广泛的哺乳动物细胞类型中追踪病毒转导和 shRNA 或 cDNA 的诱导。它们通过基于荧光的逆转录转激活剂表达的定量来实现基因表达在异质细胞群体中的均匀、时间依赖性和可逆控制。这一特性允许分离出体外和体内表现出强大诱导靶基因敲低的细胞群体,可用于人类异种移植模型中检查癌症药物靶点。